Dow Down0.44% Nasdaq Up0.35%

Boston Scientific Corporation (BSX)

-NYQ
11.41 Up 0.04(0.35%) 9:48AM EDT - NYSE Real Time Price
ProfileGet Profile for:
Boston Scientific Corporation
300 Boston Scientific Way
Marlborough, MA 01752-1234
United States - Map
Phone: 508-683-4000
Fax: 508-650-8923
Website: http://www.bostonscientific.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:23,000

Business Summary 

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker to treat heart failure; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart comprising radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, the company provides endoscopy products to treat diseases of the digestive and pulmonary systems; stone management products to treat patients with urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products; and devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs. Boston Scientific Corporation was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Boston Scientific Corporation

Corporate Governance 
Boston Scientific Corporation’s ISS Governance QuickScore as of Oct 1, 2014 is 8. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 9; Compensation: 5.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Peter Michael Nicholas , 72
Co-Founder and Chairman
N/AN/A
Mr. Michael F. Mahoney , 49
Chief Exec. Officer, Pres and Director
2.20M0.00
Mr. Kenneth J. Pucel , 47
Exec. VP of Global Operations, Quality & Technology
1.01M0.00
Mr. Timothy A. Pratt , 64
Chief Admin. Officer, Exec. VP, Gen. Counsel and Sec.
1.19M0.00
Mr. Supratim Bose , 61
Exec. VP and Pres of Asia-Pac, Middle East & Africa
890.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders